Business Description
Syntara Limited is an Australian drug development company focused on creating new treatments for blood cancers, scarring, inflammation, and organ fibrosis. Its leading drug candidate, amsulostat, is currently in clinical trials for bone marrow cancers, while other pipeline drugs are being tested for conditions ranging from hypertrophic scars to neurodegenerative diseases. Founded in 1998 and based in Frenchs Forest, Australia, the company was previously known as Pharmaxis Ltd before rebranding in December 2023.
